|
| Birmingham Alabama Mesothelioma Lung Cancer Lawyer - Biphasic Mesothelioma |
Did You Know?
Biphasic mesothelioma is the second most common type of mesothelioma cancer cell.
Biphasic Mesothelioma is not a condition unto itself, but rather it is a combination of the other two types. It can take on both the good and bad aspects of sarcomatoid mesothelioma and epithelioid mesothelioma and is 20-38% of all mesothelioma cases are biphasic or “mixed”.
There are three categories of mesothelioma cancer cells:
- Biphasic mesothelioma cancer
- Epithelioid mesothelioma cancer
- Sarcomatoid mesothelioma cancer
Biphasic mesothelioma is the second most common type of mesothelioma cancer cell. Biphasic mesothelioma does not have a unique cellular pattern unto itself; rather, biphasic mesothelioma consists of a mixture of epithelioid and sarcomatoid mesothelioma cells.
Biphasic mesothelioma cancer cases have seen an increase in occurrence over the years. Whereas biphasic cancer was once seen in approximately 25% of all mesothelioma cases, it has recently been seen in approximately 46% to 63% of all cases.
Biphasic Mesothelioma Cancer Treatment
The treatment options available for biphasic mesothelioma are the same as those used to combat epithelioid and sarcomatoid mesothelioma. Aside from having differing cellular appearances, the three mesothelioma subtypes also have differing average survival times. The mean survival time of biphasic mesothelioma cancer patients is the lowest of the three at six months.
Although the methods of treating biphasic mesothelioma cancer do not differ from those of treating epithelioid mesothelioma cancer or sarcomatoid mesothelioma cancer, the shorter average post-diagnostic survival time of biphasic mesothelioma cancer patients makes radical or more experimental treatments a more appealing option than standard treatment modalities.
Biphasic Mesothelioma - Survival Time and Treatment
Of the three mesothelioma cell types, biphasic mesothelioma has the shortest mean survival time at six months; because of this, biphasic mesothelioma sufferers might elect to choose a more experimental or radical treatment option.
Mesothelioma Lung Cancer Lawyer is not designed to provide medical advice or is intended to be for educational use only. The information provided through Mesothelioma Lung Cancer Lawyer is not a substitute for professional care and should not be used for diagnosing or treating a health problem or a disease. If you have, or suspect you may have, a health problem we can refer you to a mesothelioma doctor or lawyer in your state.
|
| |
Mesothelioma Lawyer is not designed to provide medical advice or is intended to be for educational use only. The information provided through Mesothelioma Lawyer is not a substitute for professional care and should not be used for diagnosing or treating a health problem or a disease. If you have, or suspect you may have, a health problem we can refer you to a mesothelioma doctor or lawyer in your state.
|
|
|
| |
|
| |
 |
MESOTHELIOMA LAWYER CONTACT FORM: |
 |
|
|
 |
 |
|
| |
|
| |
 |
 |
Legal |
| Mesothelioma Resource Articles |
|
|
 |
Cancer.org - Treatment Guides for Lung Cancer Patients (PDF) |
|
Gene-modified PA1-STK cells
Home to tumor sites in patients with malignant pleural mesothelioma |
|
Combined Resection, Intraperitoneal Chemotherapy and Whole Abdominal Radiation for the Treatment of Peritoneal Mesothelioma |
|
Current Therapy for Mesothelioma
by David J. Sugarbaker, MD, Jose J. Norberto, MD, and Raphael Bueno, MD . |
|
PET Imaging of Pleural Mesothelioma
by Hossein Jadvar, MD, PhD., Alan J. Fischman, MD, PhD. |
|
Mesothelioma by University of Minnesota Cancer Center |
|
Mesothelioma: A Study of 22 Cases
by Judy A. C. King, MD, PhD, J. Allan Tucker, MD, and Song W. Wong, MD, Mobile, Ala. |
|
Mesothelioma Clinical Trials
current treatment & experimental treatment trials at the Columbia University. |
|
|
|
 |
|
| |
| |
|
